← Back to Search

N/A

Peri-capsular Nerve Group (PENG) for Postoperative Pain

Phase 4

Waitlist Available

Led By Rawad Hamzi, MD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up hour 24

Awards & highlights

Study Summary

This trial is testing whether a new type of pain relief (PENG) is better than the standard pain relief (LPB) for people having hip surgery.

Eligible Conditions

Hip Pain
Postoperative Pain

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ hour 24

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~hour 24

This trial's timeline: 3 weeks for screening, Varies for treatment, and hour 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Numeric Rating Scale (NRS) Pain Score

Secondary outcome measures

Distance Ambulated

Motor Strength

NRS Pain Score

+1 more

Side effects data

From 2023 Phase 4 trial • 154 Patients • NCT05261009

Right hip dislocation

100%

80%

60%

40%

20%

Study treatment Arm

Peri-capsular Nerve Group (PENG)

Lumbar Plexus Block (LPB)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Peri-capsular Nerve Group (PENG)Experimental Treatment1 Intervention

Those subjects assigned to the PENG treatment arm will receive a PENG block using 20mL of 0.2% ropivacaine with 1:400,000 epinephrine dosed in 5mL increments with negative aspiration beforehand and between each aliquot.

Group II: Lumbar Plexus Block (LPB)Active Control1 Intervention

Those subjects assigned to the LPB treatment arm will receive a stimulation-based LPB dosed with 20cc of 0.2% ropivacaine with 1:400,000 dilution epinephrine dosed in 5mL increments with negative aspiration beforehand and between each aliquot.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Peri-capsular Nerve Group (PENG)

2022

Completed Phase 4

~160

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,240 Previous Clinical Trials

1,004,053 Total Patients Enrolled

4 Trials studying Postoperative Pain

246 Patients Enrolled for Postoperative Pain

Rawad Hamzi, MDPrincipal InvestigatorWake Forest University Health Sciences

1 Previous Clinical Trials

20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate amount of participants in this trial?

"Affirmative. According to clinicaltrials.gov, this medical research is presently enrolling 80 individuals from a single site. The listing was first posted on June 13th 2022 and was recently updated on the 30th of that same month."

Answered by AI

What is the status of Peri-capsular Nerve Group (PENG) with regards to its regulatory clearance?

"Based on our team's evaluation, the safety of Peri-capsular Nerve Group (PENG) was assigned a score of 3 as it is already approved by Phase 4 clinical trials."

Answered by AI

Does the trial welcome participants aged 70 or older?

"In accordance with the established criteria, individuals between 18 and 90 years old may be considered eligible for this clinical trial."

Answered by AI

Could I become a volunteer for this clinical exploration?

"To be eligible for this medical study, individuals must have experienced postoperative pain and should be aged between 18 to 90 years old. The clinical trial is anticipated to accept around 80 participants."

Answered by AI

Are there opportunities for volunteers to participate in this clinical research?

"According to the information hosted onclinicaltrials.gov this investigation is actively seeking participants, with initial listing of June 13th 2022 and latest update occurring at the end of that same month."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PENG Block Versus LP Block for THA Postop Pain

2022. "PENG Block Versus LP Block for THA Postop Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05261009.